OTC:OTLC | Cash Flow Statement | Oncotelic Therapeutics, Inc.

Complete source-backed cash-flow history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30$388,147.00
2026-03-31-$2.19M-$342,243.00$317,000.00
2025-12-31$250.35M-$783,017.00$462,874.00
2025-09-30-$1.05M
2025-06-30$277,856.00
2025-03-31-$298,716.00-$166,955.00$160,000.00
2024-12-31-$600,934.00-$103,890.00$41,000.00
2024-09-30-$3.3M
2024-06-30-$209,837.00
2024-03-31-$408,676.00-$231,416.00$250,000.00
2023-12-31-$735,983.00-$372,617.00$275,000.00
2023-09-30$115,309.00
2023-06-30-$6.76M
2023-03-31-$525,419.00-$251,017.00$200,000.00
2022-12-31-$5.29M-$80,680.00$68,250.00
2022-09-30-$777,935.00
2022-06-30$16.01M
2022-03-31-$4.85M-$962,668.00$491,805.00
2021-12-31-$1.79M-$1.07M$1.56M
2021-09-30-$1.56M
2021-06-30-$3.23M
2021-03-31-$2.8M-$1.25M$1.61M
2020-12-31-$3.44M-$1.49M$599,515.00
2020-09-30-$1.99M
2020-06-30$582,091.00
2020-03-31-$4.66M$31,473.00$70,000.00
2019-12-31-$3.48M-$944,395.00$6,403.00$1M
2019-09-30-$991,126.00
2019-06-30-$1.19M
2019-03-31-$976,063.00-$117,995.00$115,000.00
2018-12-31-$154,603.00-$40,045.00$40,000.00
2018-09-30-$214,033.00
2018-06-30-$153,308.00
2018-03-31-$190,794.00-$882,000.00
2017-12-31-$2.43M-$793,000.00$0.00
2017-09-30-$3.54M
2017-06-30-$3.88M
2017-03-31-$3.96M-$3.7M
2016-12-31-$3.45M-$4.23M
2016-09-30-$3.24M
2016-06-30-$3.64M
2016-03-31-$3.33M-$4.4M
2015-12-31-$3.97M-$2.97M-$1,000.00
2015-09-30-$3.59M
2015-06-30-$3.32M
2015-03-31-$2.77M-$3.5M
2014-12-31-$2.64M-$2.85M
2014-09-30-$3.45M
2014-06-30-$3.93M
2014-03-31-$2.63M-$2.62M$20.35M
2013-12-31-$2.1M-$2.13M$393,000.00
2013-09-30-$2.65M
2013-06-30-$1.65M
2013-03-31-$1.88M-$1.89M$1.51M
2012-12-31-$1.68M-$1.87M$523,000.00
2012-09-30-$2.25M
2012-06-30-$2.27M
2012-03-31-$1.89M-$2.3M$471,000.00
2011-12-31-$2.35M-$2.81M$135,000.00
2011-09-30-$3.51M
2011-06-30-$2.93M
2011-03-31-$863,000.00-$3.59M-$12,000.00$1.63M
2010-12-31-$1.74M-$2.48M-$37,000.00$669,000.00
2010-09-30-$13.54M
2010-06-30$2.54M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$249.28M-$1.38M$1.39M
2024-12-31-$4.52M-$740,277.00$656,000.00
2023-12-31-$7.9M-$1.32M$1.25M
2022-12-31$5.09M-$1.45M$1.13M
2021-12-31-$9.39M-$4.43M$4.53M
2020-12-31-$9.5M-$2.81M$3.22M
2019-12-31-$6.64M-$2.28M$189,286.00$2.17M
2018-12-31-$712,738.00-$240,980.00$240,000.00
2017-12-31-$13.81M-$10.93M$8.51M
2016-12-31-$13.65M-$15.24M
2015-12-31-$13.65M-$11.93M$13,000.00
2014-12-31-$12.65M-$12.15M$17,000.00
2013-12-31-$8.28M-$7M-$35,000.00$9.1M
2012-12-31-$8.08M-$8.34M-$8,000.00$3.32M
2011-12-31-$9.65M-$11.78M$17.15M
2010-12-31-$23.77M-$20.43M$3,000.00$11.09M
2009-12-31-$24.73M-$28.67M$109,000.00$2.93M$21.39M